Innovative Drug Development Arrivo Bio specializes in advanced drug development processes, making it a prime candidate for collaborations with pharmaceutical giants seeking cutting-edge research partners to accelerate pipeline growth.
Growth Potential With a revenue range of 10 to 25 million dollars and recent collaborations ongoing in phase 2 clinical trials, there are significant opportunities for strategic investments or M&A to scale operations.
Strategic Partnerships The recent partnership with Lamassu Bio in clinical trials indicates a proactive approach to collaboration, suggesting potential interest in joint ventures or licensing agreements with innovative biotech firms.
Market Positioning Positioned within the competitive biotech sector alongside industry leaders like Moderna and Pfizer, Arrivo Bio presents an opportunity for larger players to expand their innovative research portfolios.
Technology Adoption Utilizing a robust tech stack including cloud services, analytics, and SEO tools, Arrivo Bio demonstrates operational maturity, making it attractive for technology licensing or integration services to enhance their research infrastructure.
$10B
$10B
$10B
$1B$10B
$10B
$10B
$10B
$10B
$10B
$10BArrivo Bio uses 8 technology products and services including RSS, Cloudflare, Microsoft 365, and more. Explore Arrivo Bio's tech stack below.
| Arrivo Bio Email Formats | Percentage |
| FLast@arrivobio.com | 100% |
Biotechnology ResearchNorth Carolina, United States11-50 Employees
At Arrivo, we strive to set a new standard in drug development that starts with the selection of drug candidates and runs throughout clinical development. Our approach and decision-making has delivered a history of excellent returns and product successes that makes us the trusted partner for industry and investors.
Company Overview
Funding & FinancialsArrivo Bio's revenue is estimated to be in the range of $10M$25M
Funding & FinancialsArrivo Bio's revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com